Skip to main content
. 2009 Sep 11;75(22):6955–6962. doi: 10.1128/AEM.00375-09

TABLE 1.

Pathotype distribution among the 256 E. coli isolates from chickens fed with antimicrobial agents in the two studies

Study and treatment (n) No. (%) of isolates
“Other” ExPEC APEC Commensal
I
    Control (20) 3 (15.0) 6 (3.3) 11 (55.0)
    Bambermycin (14) 2 (14.3) 3 (21.4) 9 (64.3)
    Penicillin (17) 2 (11.8) 7 (41.2) 8 (47.0)
    Salinomycin (21) 4 (19.0) 4 (19.0) 13 (62.0)
    Bacitracin (19) 3 (15.8) 1 (5.3) 15 (78.9)
    Salinomycin + bacitracin (18) 1 (5.6) 6 (3.3) 11 (61.1)
        Total (109) 15 (13.8) 27 (24.7) 67 (61.5)
        Pa 0.50 0.17 0.50
II
    Control (29) 0 (0.0) 3 (10.3) 26 (89.7)
    Chlortetracycline (18) 0 (0.0) 0 (0.0) 18 (100)
    Virginiamycin, 11 ppm (23) 0 (0.0) 7 (30.4) 16 (69.6)
    Virginiamycin, 22 ppm (31) 0 (0.0) 2 (6.5) 29 (93.5)
    Monensin (21) 0 (0.0) 1 (4.8) 20 (95.2)
    Narasin (25) 0 (0.0) 4 (16.0) 21 (84.0)
        Total (147) 0 (0.0) 17 (11.6) 130 (88.4)
        P NDb 0.02* 0.02*
Total (256) 15 (5.8) 44 (17.2) 197 (77.0)
a

P value obtained by Cochran-Mantel-Haenszel test. *, statistically significant difference between treatment groups (P ≤ 0.05).

b

ND, not determined (or estimated).